Tuesday, May 18, 2021

Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial

A COVID-19 vaccine developed by pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) has shown strong rates of neutralising antibody responses against the infectious Coronavirus disease in the Phase-II trial.

from Zee News :Zee News - Health https://ift.tt/3hyEotX
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Toothache to immunity boost: Acharya Balkrishna reveals why ginger is a powerful everyday superfood

Acharya Balkrishna shares how ginger, a humble kitchen staple, is packed with powerful healing properties that go far beyond flavour. From e...